Glutathione
Glutathione
Glutathione is the body's primary endogenous antioxidant, produced in every cell to neutralise free radicals and protect cellular integrity — but levels fall naturally with age and stress. A six-month human clinical trial demonstrated 30–35% increases in blood glutathione across multiple tissue compartments alongside significant reductions in oxidative stress markers. Separately, a dermatology trial confirmed measurable reductions in skin melanin index and improvements in skin clarity and moisture, reflecting glutathione's dual role in antioxidant protection and skin health.
Supplied as research-grade lyophilised powder. Available in 1500mg format. For research purposes only.
Research Stack Builder
Build Your Research Stack
Curated combinations based on what researchers actually stack — backed by published data, priced to save.
Stack with Glutathione
Why researchers stack these
- 01Brightening, structure & cellular energy
- 02Counterbalancing pigmentation pathways studied
- 03Complete skin antioxidant protocol
Full research context
Glutathione reduces oxidative stress and inhibits tyrosinase, shifting melanin production toward lighter pheomelanin — producing measurable skin brightening in clinical trials with 30–35% tissue GSH increases. GHK-Cu adds the structural component: collagen density and extracellular matrix repair that brightening alone does not address. MT2 is the pigmentation counterpart — researchers combine these to study the interplay between tyrosinase inhibition and MC1R-driven melanogenesis. NAD+ fuels the antioxidant regeneration cycle, preventing Glutathione depletion under the demands of a comprehensive skin protocol.
Recovery & Repair Protocol
The most studied peptide combination for tissue repair, injury recovery & musculoskeletal healing
Why researchers stack these
- 01Non-competing structural repair pathways
- 02BPC-157 angiogenesis + TB-500 satellite cell activation
- 03GHK-Cu adds the extracellular matrix layer both lack
Full research context
BPC-157 and TB-500 are the two most frequently co-researched repair peptides in published literature, acting through complementary mechanisms — BPC-157 via nitric oxide pathways and angiogenesis, TB-500 via actin-sequestering and satellite cell activation. GHK-Cu rounds out the stack by supporting collagen synthesis and the extracellular matrix that both compounds do not directly address, while reducing the oxidative load that slows tissue recovery.
Metabolic & Body Recomposition
Most popular Peptide Pal stack — two non-competing fat loss axes with skin integrity support
Why researchers stack these
- 01GLP-1 triple agonism + GH axis — two distinct fat loss pathways
- 02Skin integrity preserved throughout recomposition
- 03Most purchased together on Peptide Pal
Full research context
Retatrutide and Tesamorelin address body composition through two non-competing mechanisms. Retatrutide's triple receptor agonism drives broad metabolic improvement and appetite regulation; Tesamorelin is FDA-approved for visceral adipose reduction through the growth hormone axis — a distinct mechanism. GHK-Cu supports skin integrity during recomposition; rapid fat loss without collagen support produces visible skin laxity that is far harder to address after the fact.
Cognitive Performance Stack
Neuropeptides studied for synergistic cognitive enhancement, focus & stress resilience — no sedation
Why researchers stack these
- 01BDNF stimulation balanced by GABA modulation
- 02Focus without anxiety — three non-competing pathways
- 03NAD+ fuels the neuronal energy demand
Full research context
Semax and Selank are registered pharmaceuticals with distinct mechanisms. Semax drives BDNF upregulation and cortical processing speed; Selank reduces the stress-induced cognitive interference that can blunt that effect, without sedation or dependency. NAD+ provides the cellular energy substrate that enhanced neuronal activity demands — researchers consistently report that this combination delivers balanced cognitive performance that neither compound achieves alone.
Skin & Glow Protocol
Collagen synthesis, antioxidant protection & melanin research in one comprehensive skin stack
Why researchers stack these
- 01Collagen, antioxidant & pigmentation — three skin pillars
- 02Tyrosinase inhibition counterbalances MC1R agonism for pathway research
- 03Structural integrity maintained alongside brightening
Full research context
GHK-Cu stimulates collagen synthesis and modulates over 4,000 genes involved in skin repair and inflammatory control — addressing the structural layer. Glutathione reduces oxidative stress and inhibits tyrosinase, producing measurable skin brightening with 30–35% tissue GSH increases confirmed in human RCTs. MT2 drives eumelanin synthesis via MC1R agonism, and researchers frequently combine it with Glutathione to study the interplay between melanocortin-driven pigmentation and tyrosinase inhibition simultaneously. Together these three represent the most comprehensive skin research protocol available.
Cellular Longevity Protocol
Three compounds that decline together with age — combined restoration for mitochondrial & cellular health
Why researchers stack these
- 01All three decline together with age — parallel restoration
- 02Mitochondrial energy, AMPK signalling & antioxidant protection
- 03Most complete cellular longevity protocol available
Full research context
NAD+, MOTS-c, and glutathione all decline measurably with age through parallel but distinct pathways. NAD+ restores sirtuin and PARP function essential for mitochondrial biogenesis and DNA repair — declining up to 50% by age 60. MOTS-c is the mitochondria-derived peptide that activates AMPK signalling and declines alongside NAD+; their combined restoration is the most researched longevity intervention. Glutathione provides the antioxidant protection that prevents cellular damage during the heightened metabolic activity that NAD+ and MOTS-c restoration drives — completing what researchers describe as the foundational cellular longevity triad.
Research & Studies
Peer-reviewed research supporting Glutathione
Oral Glutathione Supplementation Elevates Tissue Stores and Reduces Oxidative Stress in Healthy Adults
A six-month randomised, double-blind, placebo-controlled trial in 54 healthy adult volunteers demonstrated that oral glutathione supplementation at 250mg and 1,000mg per day produced dose-dependent increases in blood glutathione levels of up to 30–35% across multiple tissue compartments including erythrocytes, lymphocytes, and plasma. Higher-dose participants also showed a significant reduction in the oxidised-to-reduced glutathione ratio — a validated marker of systemic oxidative stress — and a measurable decrease in skin melanin index. This human trial provides direct evidence that oral glutathione is bioavailable and effective at modulating antioxidant status and pigmentation markers.
Glutathione Reduces Skin Melanin and Improves Skin Condition in Human Clinical Trial
A randomised, double-blind, placebo-controlled clinical trial evaluated oral glutathione supplementation in 60 healthy female participants over 12 weeks. Compared to placebo, glutathione-treated participants showed significant reductions in melanin index measured at six skin sites, alongside improvements in skin moisture, smoothness, and reduction in UV spot count as assessed by objective skin analysis. Glutathione’s depigmenting mechanism operates through inhibition of tyrosinase and switching melanin synthesis from eumelanin (dark) to pheomelanin (lighter), providing human evidence of both antioxidant and skin brightening benefits from supplementation.